LIACX | PMBJX | LIACX / PMBJX | |
Total Expense Ratio | 1.82 | 0.78 | 233% |
Annual Report Gross Expense Ratio | 1.85 | 0.78 | 237% |
Fund Existence | 25 years | 25 years | - |
Gain YTD | 3.568 | 2.303 | 155% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 1000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.54B | 31.9B | 8% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 2.35 | -3.03 | -78% |
Returns for 3 years | 42.07 | 48.67 | 86% |
Returns for 5 years | -23.94 | 34.98 | -68% |
Returns for 10 years | -87.24 | 98.61 | -88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
DFUV | 44.24 | 0.13 | +0.29% |
Dimensional US Marketwide Value ETF | |||
TXS | 36.05 | 0.03 | +0.08% |
Texas Capital Texas Equity Index ETF | |||
LFAI | 155.51 | N/A | N/A |
LifeX 2050 Longevity Income ETF | |||
ISHG | 75.86 | -0.06 | -0.08% |
iShares 1-3 Year International TrsBd ETF |